Publications by authors named "Ronald Lieberman"

Claim this Profile
C
Cardiovascular safety monitoring during oncology drug development and therapy.
J Rick Turner, Gopi Krishna Panicker, Dilip R Karnad, Christopher H Cabell, Ronald Lieberman

Am J Ther· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer.
Cornelius F Waller, Ihor Vynnychenko, Igor Bondarenko, Yaroslav Shparyk, Jeffrey P Hodge, Ronald Lieberman

Clin Lung Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in the treatment of peripheral T-cell lymphomas: an orphan no more.
Ronald Lieberman

Am J Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The androgen receptor, androgen synthesis, and new designer antiandrogens for metastatic castration-resistant prostate cancer: teaching old dogs new tricks.
Ronald Lieberman

Am J Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food and Drug Administration approval of cetuximab and a new KRAS genetic test for metastatic colorectal cancer: major advance but just the tip of the biomarker iceberg.
Ronald Lieberman

Am J Ther· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized medicine enters the US marketplace: KRAS, anti-EGFR monoclonal antibodies, and colon cancer.
Ronald Lieberman

Am J Ther· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lycopene in cancer prevention and treatment.
Soley Seren, Ronald Lieberman, Ulas D Bayraktar, Elisabeth Heath, Kazim Sahin

Am J Ther· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.
Anne R Simoneau, Eugene W Gerner, Ray Nagle, Argyrios Ziogas, Sharon Fujikawa-Brooks, Ronald Lieberman

Cancer Epidemiol Biomarkers Prev· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
Steven R Alberts, Paul J Novotny, Jeff A Sloan, John Danella, David G Bostwick, Ronald Lieberman

Am J Ther· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
James R Marshall, Wael Sakr, David Wood, Donna Berry, Catherine Tangen, Ronald Lieberman

Cancer Epidemiol Biomarkers Prev· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of an epidermal growth factor receptor tyrosine kinase inhibitor on actin remodeling in an in vitro bladder cancer carcinogenesis model.
Yusheng Jin, Kenneth K Iwata, Arie Belldegrun, Robert Figlin, Allan Pantuck, Ronald Lieberman

Mol Cancer Ther· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer.
Philip M Arlen, James L Gulley, Nushin Todd, Ronald Lieberman, Seth M Steinberg

J Urol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged response to nilutamide in a patient with stage D0.5 prostate cancer who previously failed androgen deprivation therapy.
Nushin F Todd, Ronald Lieberman, James L Gulley, William Dahut, Philip M Arlen

Am J Ther· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.
Jeri Kim, Peiyu Sun, Ying-Wai Lam, Patricia Troncoso, Anita L Sabichi, Ronald Lieberman

Cancer Epidemiol Biomarkers Prev· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer.
Ronald Lieberman

Am J Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia.
Vered Stearns, Andrew Coop, Baljit Singh, Ann Gallagher, Hideko Yamauchi, Ronald Lieberman

Clin Cancer Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio.
Howard L Parnes, Margaret G House, Jacob Kagan, David J Kausal, Ronald Lieberman

J Urol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.
Chris H Takimoto, Kira Glover, Xiaoke Huang, Steven A Hayes, Lilia Gallot, Ronald Lieberman

Cancer Epidemiol Biomarkers Prev· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoroscopically guided interlaminar cervical epidural injections.
Ronald Lieberman, Paul Dreyfuss, Ray Baker

Arch Phys Med Rehabil· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials referral resource. Current NCI-sponsored clinical trials in prostate cancer: prevention, treatment, supportive care, and imaging.
Alison Martin, Ronald Lieberman, Howard Parnes, Mason Schoenfeldt

Oncology (Williston Park)· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoprevention of prostate cancer: current status and future directions.
Ronald Lieberman

Cancer Metastasis Rev· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving strategies for prostate cancer chemoprevention trials.
Ronald Lieberman

World J Urol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis